NCT06829693View on ClinicalTrials.gov

Evaluation of the Incidence of Psychiatric Disorders As a Function of First-line Antiepileptic Drug Prescribing Practices: Use of Assurance Maladie Databases

Not yet recruitingOBSERVATIONAL

Enrollment

355,000

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2026

Conditions

EpilepsySide Effects of Drugs

Trial Locations (1)

75015

European Georges Pompidou Hospital, Paris

All Listed Sponsors

collaborator

Ministry of Health, France

OTHER_GOV

collaborator

GHU Paris Psychiatry & Neurosciences

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06829693 - Evaluation of the Incidence of Psychiatric Disorders As a Function of First-line Antiepileptic Drug Prescribing Practices: Use of Assurance Maladie Databases | Biotech Hunter | Biotech Hunter